Cytokine responses to quantiferon peptides in pediatric tuberculosis: A pilot study

Journal of Infection

Volumn 68, Issue 1, 2014, Pages 62-70

  Armand, Marine ^a   Chhor, Vibol ^b,c   de Lauzanne, Agathe ^a   Guérin El Khourouj, Valérie ^a   Pédron, Béatrice ^a   Jeljeli, Mohamed ^a   Gressens, Pierre ^b,c   Faye, Albert ^a   Sterkers, Ghislaine ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Children; Cytokines; IL 13; IL 2; IL 5; IP 10; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; MYCOBACTERIUM ANTIGEN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; INFANT; LATENT TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PILOT STUDY; PRESCHOOL CHILD; PROTEIN DETERMINATION; SCHOOL CHILD; TUBERCULOSIS;

CHILDREN; CYTOKINES; IL-13; IL-2; IL-5; IP-10; TUBERCULOSIS;

ADOLESCENT; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; HUMANS; IMMUNOLOGIC TESTS; INFANT; MALE; PILOT PROJECTS; ROC CURVE; TUBERCULOSIS;

EID: 84888877611     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.08.005     Document Type: Article

References (58)

1. Zuniga J., Torres-Garcia D., Santos-Mendoza T., Rodriguez-Reyna T.S., Granados J., Yunis E.J. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol 2012, 2012:193923.
2. Nelson L.J., Wells C.D. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004, 8(5):636-647.
3. Oberhelman R.A., Soto-Castellares G., Gilman R.H., Caviedes L., Castillo M.E., Kolevic L., et al. Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis 2010, 10(9):612-620.
4. Nicol M.P., Zar H.J. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev 2011, 12(1):16-21.
5. Graham S.M., Ahmed T., Amanullah F., Browning R., Cardenas V., Casenghi M., et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012, 205(Suppl. 2):S199-S208.
6. Yang Z., Kong Y., Wilson F., Foxman B., Fowler A.H., Marrs C.F., et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis 2004, 38(2):199-205.
7. Lewinsohn D.A., Gennaro M.L., Scholvinck L., Lewinsohn D.M. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis 2004, 8(5):658-674.
8. Pai M., Riley L.W., Colford J.M. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004, 4(12):761-776.
9. Machingaidze S., Wiysonge C.S., Gonzalez-Angulo Y., Hatherill M., Moyo S., Hanekom W., et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011, 30(8):694-700.
10. Mandalakas A.M., Detjen A.K., Hesseling A.C., Benedetti A., Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011, 15(8):1018-1032.
11. Ruhwald M., Aabye M.G., Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 2012, 12(2):175-187.
12. John S.H., Kenneth J., Gandhe A.S. Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies. Biomarkers 2012, 17(1):1-8.
13. Lighter-Fisher J., Peng C.H., Tse D.B. Cytokine responses to QuantiFERON(R) peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis. Int J Tuberc Lung Dis 2010, 14(12):1548-1555.
14. Sterling T.R., Martire T., de Almeida A.S., Ding L., Greenberg D.E., Moreira L.A., et al. Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination. Pediatrics 2007, 120(4):e912-e921.
15. Kumar N.P., Anuradha R., Suresh R., Ganesh R., Shankar J., Kumaraswami V., et al. Suppressed type 1, type 2, and type 17 cytokine responses in active tuberculosis in children. Clin Vaccine Immunol 2011, 18(11):1856-1864.
16. Wiseman C.A., Gie R.P., Starke J.R., Schaaf H.S., Donald P.R., Cotton M.F., et al. A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J 2012, 31(4):347-352.
17. Blandinières A., Agathe de Lauzanne, Guérin-El Khourouj V., Gourgouillon N., See H., et al. QuantiFERON to diagnose infection by mycobacterium tuberculosis: performance in infants and older children. J Infect 2013, [Epub ahead of print].
18. Debord C., De Lauzanne A., Gourgouillon N., Guerin-El Khourouj V., Pedron B., Gaudelus J., et al. Interferon-gamma release assay performance for diagnosing tuberculosis disease in 0- to 5-year-old children. Pediatr Infect Dis J 2011, 30(11):995-997.
19. Beck J.R., Shultz E.K. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986, 110(1):13-20.
20. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3(1):32-35.
21. Ruhwald M., Bodmer T., Maier C., Jepsen M., Haaland M.B., Eugen-Olsen J., et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. The Eur Respir J 2008, 32(6):1607-1615.
22. Alsleben N., Ruhwald M., Russmann H., Marx F.M., Wahn U., Magdorf K. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Scand J Infect Dis 2012, 44(4):256-262.
23. Goletti D., Raja A., Syed Ahamed Kabeer B., Rodrigues C., Sodha A., Carrara S., et al. Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?. PloS One 2010, 5(9):e12577.
24. Goletti D., Raja A., Ahamed Kabeer B.S., Rodrigues C., Sodha A., Butera O., et al. IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 2010, 61(2):133-143.
25. Rubbo P.A., Nagot N., Le Moing V., Brabet M., Bourdin A., Nogue E., et al. Multicytokine detection improves latent tuberculosis diagnosis in health care workers. J Clin Microbiol 2012, 50(5):1711-1717.
26. Wang X., Jiang J., Cao Z., Yang B., Zhang J., Cheng X. Diagnostic performance of multiplex cytokine and chemokine assay for tuberculosis. Tuberculosis (Edinb) 2012, 92(6):513-520.
27. Jacobs M., Togbe D., Fremond C., Samarina A., Allie N., Botha T., et al. Tumor necrosis factor is critical to control tuberculosis infection. Microbes Infect 2007, 9(5):623-628.
28. Keane J., Gershon S., Wise R.P., Mirabile-Levens E., Kasznica J., Schwieterman W.D., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001, 345(15):1098-1104.
29. Caccamo N., Guggino G., Joosten S.A., Gelsomino G., Di Carlo P., Titone L., et al. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40(8):2211-2220.
30. Casey R., Blumenkrantz D., Millington K., Montamat-Sicotte D., Kon O.M., Wickremasinghe M., et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PloS One 2010, 5(12):e15619.
31. Millington K.A., Innes J.A., Hackforth S., Hinks T.S., Deeks J.J., Dosanjh D.P., et al. Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007, 178(8):5217-5226.
32. Jamil B., Shahid F., Hasan Z., Nasir N., Razzaki T., Dawood G., et al. Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 2007, 87(4):279-287.
33. Dlugovitzky D., Bay M.L., Rateni L., Urizar L., Rondelli C.F., Largacha C., et al. Invitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement. Scand J Immunol 1999, 49(2):210-217.
34. Smith S.M., Klein M.R., Malin A.S., Sillah J., McAdam K.P., Dockrell H.M. Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis (Edinb) 2002, 82(1):7-13.
35. Geffner L., Yokobori N., Basile J., Schierloh P., Balboa L., Romero M.M., et al. Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun 2009, 77(11):5025-5034.
36. Khader S.A., Bell G.K., Pearl J.E., Fountain J.J., Rangel-Moreno J., Cilley G.E., et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007, 8(4):369-377.
37. Szeliga J., Daniel D.S., Yang C.H., Sever-Chroneos Z., Jagannath C., Chroneos Z.C. Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis. Tuberculosis (Edinb) 2008, 88(1):7-20.
38. Hasan Z., Zaidi I., Jamil B., Khan M.A., Kanji A., Hussain R. Elevated exvivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis. BMC Immunol 2005, 6:14.
39. Harari A., Rozot V., Enders F.B., Perreau M., Stalder J.M., Nicod L.P., et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 2011, 17(3):372-376.
40. Nemeth J., Winkler H.M., Zwick R.H., Muller C., Rumetshofer R., Boeck L., et al. Peripheral T cell cytokine responses for diagnosis of active tuberculosis. PloS One 2012, 7(4):e35290.
41. Wallis R.S., Pai M., Menzies D., Doherty T.M., Walzl G., Perkins M.D., et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 375(9729):1920-1937.
42. Petruccioli E., Petrone L., Vanini V., Sampaolesi A., Gualano G., Girardi E., et al. IFNgamma/TNFalpha specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 2013, 66(6):475-486.
43. Gourgouillon N., de Lauzanne A., Cottart C.H., Curis E., Debord C., Guerin-El Khourouj V., et al. TNF-alpha/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study. Pediatr Res 2012, 72(4):370-374.
44. Whittaker E., Gordon A., Kampmann B. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?. PloS One 2008, 3(12):e3901.
45. Yassin M.A., Petrucci R., Garie K.T., Harper G., Arbide I., Aschalew M., et al. Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?. PloS One 2011, 6(9):e23733.
46. Doherty M., Wallis R.S., Zumla A. Biomarkers for tuberculosis disease status and diagnosis. Curr Opin Pulm Med 2009, 15(3):181-187.
47. Demissie A., Wassie L., Abebe M., Aseffa A., Rook G., Zumla A., et al. The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon. Infect Immun 2006, 74(5):2817-2822.
48. Ordway D.J., Costa L., Martins M., Silveira H., Amaral L., Arroz M.J., et al. Increased interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J Infect Dis 2004, 190(4):756-766.
49. Day C.L., Abrahams D.A., Lerumo L., Janse van Rensburg E., Stone L., O'Rie T., et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J Immunol 2011, 187(5):2222-2232.
50. Roberts T., Beyers N., Aguirre A., Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta, and interleukin-4 mRNA levels. J Infect Dis 2007, 195(6):870-878.
51. Sodhi A., Gong J., Silva C., Qian D., Barnes P.F. Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis 1997, 25(3):617-620.
52. PrabhuDas M., Adkins B., Gans H., King C., Levy O., Ramilo O., et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 2011, 12(3):189-194.
53. Dlugovitzky D., Bay M.L., Rateni L., Fiorenza G., Vietti L., Farroni M.A., et al. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB). Clin Exp Immunol 2000, 122(3):343-349.
54. Kim Y., Kim K., Joe J., Park H., Lee M., Choi Y., et al. Changes in the levels of interferon-gamma and transforming growth factor-beta influence bronchial stenosis during the treatment of endobronchial tuberculosis. Respiration 2007, 74(2):202-207.
55. Sahiratmadja E., Alisjahbana B., de Boer T., Adnan I., Maya A., Danusantoso H., et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007, 75(2):820-829.
56. Morosini M., Meloni F., Uccelli M., Marone Bianco A., Solari N., Fietta A.M. Exvivo evaluation of PPD-specific IFN-gamma or IL-5 secreting cells in the peripheral blood and lungs of patients with tuberculosis. Int J Tuberc Lung Dis 2005, 9(7):753-759.
57. van Crevel R., Karyadi E., Preyers F., Leenders M., Kullberg B.J., Nelwan R.H., et al. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J Infect Dis 2000, 181(3):1194-1197.
58. Lalor M.K., Smith S.G., Floyd S., Gorak-Stolinska P., Weir R.E., Blitz R., et al. Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 2010, 28(6):1635-1641.